These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 24137952)

  • 21. [Successful treatment of a patient with two hematologic tumors: double-hit lymphoma and acute myelomonoblastic leukemia].
    Lukina AE; Bariakh EA; Kravchenko SK; Nareĭko MV; Kuz'mina LA; Parovichnikova EN; Obukhova TN; Kovrigina AM; Magomedova AU
    Ter Arkh; 2014; 86(7):80-4. PubMed ID: 25314782
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term disease-free survival in patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation.
    Schetelig J; Fetscher S; Reichle A; Berdel WE; Beguin Y; Brunet S; Caballero D; Majolino I; Hagberg H; Johnsen HE; Kimby E; Montserrat E; Stewart D; Copplestone A; Rösler W; Pavel J; Kingreen D; Siegert W
    Haematologica; 2003 Nov; 88(11):1272-8. PubMed ID: 14607756
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term outcomes of autologous stem cell transplantation for peripheral T-cell lymphomas across the Thames Valley (1997-2012).
    Sims MC; Newell K; Eyre TA; Hatton C; Collins GP
    Br J Haematol; 2015 May; 169(3):452-5. PubMed ID: 25399667
    [No Abstract]   [Full Text] [Related]  

  • 24. Combination chemotherapy followed by autologous stem cell transplant for enteropathy-associated T-cell lymphoma.
    Lennard A
    Br J Haematol; 2007 Apr; 137(2):170; author reply 171. PubMed ID: 17391498
    [No Abstract]   [Full Text] [Related]  

  • 25. High dose chemotherapy followed by autologous haemopoietic stem cell transplant in multiple myeloma.
    Kumar L; Raju GM; Ganessan K; Shawgi S; Menon H; Wadhwa J; Sharma A; Singh R; Kochupillai V
    Natl Med J India; 2003; 16(1):16-21. PubMed ID: 12715951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autologous stem cell transplantation in adult patients with peripheral T-cell lymphoma: a nation-wide survey.
    Jantunen E; Wiklund T; Juvonen E; Putkonen M; Lehtinen T; Kuittinen O; Franssila K; Söderström KO; Leppä S; Elonen E; Remes K; Nousiainen T
    Bone Marrow Transplant; 2004 Feb; 33(4):405-10. PubMed ID: 14676776
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Successful treatment of advanced peripheral T-cell lymphoma with an angiocentric growth pattern complicated with hemophagocytic syndrome by high-dose chemotherapy and autologous peripheral blood stem cell transplantation.
    Sato T; Kogawa K; Iyama S; Kobayashi D; Sato Y; Kuribayashi K; Takada K; Hagiwara S; Oku T; Takahashi S; Matsunaga T; Takahashi M; Terui T; Kato J; Niitsu Y
    Ann Hematol; 2002 Dec; 81(12):739-43. PubMed ID: 12483373
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How I treat enteropathy-associated T-cell lymphoma.
    Di Sabatino A; Biagi F; Gobbi PG; Corazza GR
    Blood; 2012 Mar; 119(11):2458-68. PubMed ID: 22271451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Four versus six courses of a dose-escalated cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) regimen plus etoposide (megaCHOEP) and autologous stem cell transplantation: early dose intensity is crucial in treating younger patients with poor prognosis aggressive lymphoma.
    Schmitz N; Kloess M; Reiser M; Berdel WE; Metzner B; Dorken B; Kneba M; Trumper L; Loeffler M; Pfreundschuh M; Glass B;
    Cancer; 2006 Jan; 106(1):136-45. PubMed ID: 16331635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term remission in a patient with hepatosplenic gammadelta T cell lymphoma treated with bortezomib and high-dose CHOP-like chemotherapy followed by autologous peripheral stem cell transplantation.
    Otrock ZK; Hatoum HA; Salem ZM; Tawil A; Mahfouz RA; Zaatari GS; Bazarbachi A
    Ann Hematol; 2008 Dec; 87(12):1023-4. PubMed ID: 18587577
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical and pathological diagnosis of peripheral T-cell lymphoma and emerging treatment options: A case-based discussion.
    Said J; Pinter-Brown L
    Clin Adv Hematol Oncol; 2009 Nov; 7(11):S1, S4-13; quiz S15. PubMed ID: 20095101
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effectiveness of dose-intensive polychemotherapy with autologous hemopoietic cell transplantation for high-grade non-Hodgkin lymphoma].
    Alekseeva IuA; Zaritskiĭ AIu; Medvedeva NV; Mikhaĭlova NB; Zubarovskaia LS; Afanas'ev BV
    Vopr Onkol; 2003; 49(1):66-70. PubMed ID: 12715373
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sequential chemotherapy by CHOP and DHAP regimens followed by high-dose therapy with stem cell transplantation induces a high rate of complete response and improves event-free survival in mantle cell lymphoma: a prospective study.
    Lefrère F; Delmer A; Suzan F; Levy V; Belanger C; Djabarri M; Arnulf B; Damaj G; Maillard N; Ribrag V; Janvier M; Sebban C; Casasnovas RO; Bouabdallah R; Dreyfus F; Verkarre V; Delabesse E; Valensi F; McIntyre E; Brousse N; Varet B; Hermine O
    Leukemia; 2002 Apr; 16(4):587-93. PubMed ID: 11960337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intensive methotrexate and cytarabine followed by high-dose chemotherapy with autologous stem-cell rescue in patients with newly diagnosed primary CNS lymphoma: an intent-to-treat analysis.
    Abrey LE; Moskowitz CH; Mason WP; Crump M; Stewart D; Forsyth P; Paleologos N; Correa DD; Anderson ND; Caron D; Zelenetz A; Nimer SD; DeAngelis LM
    J Clin Oncol; 2003 Nov; 21(22):4151-6. PubMed ID: 14615443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of clinical outcome after autologous stem cell transplantation between patients with peripheral T-cell lymphomas and diffuse large B-cell lymphoma.
    Sohn BS; Park I; Kim EK; Yoon DH; Lee SS; Kang BW; Jang G; Choi YH; Kim C; Lee DH; Kim S; Huh J; Suh C
    Bone Marrow Transplant; 2009 Sep; 44(5):287-93. PubMed ID: 19234508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Survival of patients with peripheral T-cell lymphoma after first relapse or progression: spectrum of disease and rare long-term survivors.
    Mak V; Hamm J; Chhanabhai M; Shenkier T; Klasa R; Sehn LH; Villa D; Gascoyne RD; Connors JM; Savage KJ
    J Clin Oncol; 2013 Jun; 31(16):1970-6. PubMed ID: 23610113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Initial treatment of aggressive lymphoma with high-dose chemotherapy and autologous stem-cell support.
    Milpied N; Deconinck E; Gaillard F; Delwail V; Foussard C; Berthou C; Gressin R; Lucas V; Colombat P; Harousseau JL;
    N Engl J Med; 2004 Mar; 350(13):1287-95. PubMed ID: 15044639
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peripheral T-cell lymphoma in children and adolescents: a single-institution experience.
    Al Mahmoud R; Weitzman S; Schechter T; Ngan B; Abdelhaleem M; Alexander S
    J Pediatr Hematol Oncol; 2012 Nov; 34(8):611-6. PubMed ID: 23042011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence and outcomes of rare T cell lymphomas from the T Cell Project: hepatosplenic, enteropathy associated and peripheral gamma delta T cell lymphomas.
    Foss FM; Horwitz SM; Civallero M; Bellei M; Marcheselli L; Kim WS; Cabrera ME; Dlouhy I; Nagler A; Advani RH; Pesce EA; Ko YH; Montoto S; Chiattone C; Moskowitz A; Spina M; Cesaretti M; Biasoli I; Federico M
    Am J Hematol; 2020 Feb; 95(2):151-155. PubMed ID: 31709579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful treatment of a child with late-onset T-cell post-transplant lymphoproliferative disorder/lymphoma.
    Williams KM; Higman MA; Chen AR; Schwartz CL; Wharam M; Colombani P; Arceci RJ
    Pediatr Blood Cancer; 2008 Mar; 50(3):667-70. PubMed ID: 17318876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.